Viewing Study NCT02371369

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:09 PM
Ignite Modification Date: 2026-06-06 @ 12:37 PM
Study NCT ID: NCT02371369
Status: COMPLETED
Last Update Posted: 2022-05-11
First Post: 2015-02-19
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
Sponsor: Daiichi Sankyo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pigmented Villonodular Synovitis View
None Giant Cell Tumors of the Tendon Sheath View
None Tenosynovial Giant Cell Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PLX3397 View
None Pexidartinib View
None Colony Stimulating Factor 1 Receptor (CSF-1R) inhibitor View